Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).

被引：2
|
作者：
Naito, Yoichi
Kawai, Akira
Araki, Nobuhito
Ozaki, Toshifumi
Sugiura, Hideshi
Yazawa, Yasuo
Morioka, Hideo
Matsumine, Akihiko
Hiraiwa, Masahide
Asami, Shun
Isu, Kazuo
机构：
[1] Natl Canc Ctr Hosp East, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[4] Okayama Univ Hosp, Okayama, Japan
[5] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[6] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[7] Keio Univ, Tokyo, Japan
[8] Mie Univ, Grad Sch Med, Tsu, Mie, Japan
[9] Eisai, Tokyo, Japan
[10] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.10567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10567
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Exatecan (DX-8951f), a new topoisomerase I-inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS):: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pink, D
    Reichardt, P
    Nielsen, S
    Bauer, S
    Hartmann, JT
    Schöffski, P
    van Oosterom, AT
    Daugaard, S
    Stoichkov, K
    Hermans, C
    Judson, IR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 830S - 830S
  • [32] PAZOPANIB (GW786034) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY SOFT TISSUE SARCOMA (STS); A PHASE II STUDY FROM THE EORTC STBSG (EORTC 62043)
    Sleijfer, S.
    Ray-Coquard, I.
    Papai, Z.
    Le Cesne, A.
    Schoeffski, P.
    Collin, F.
    Pandite, L.
    Marreaud, S.
    De brauwer, A.
    Blay, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 267 - 267
  • [33] ORAL PIRITREXIM - A PHASE-II STUDY IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    SCHIESEL, JD
    CARABASI, M
    MAGILL, G
    CASPER, E
    CHENG, E
    MARKS, L
    FEYZI, J
    CLENDENINN, NJ
    SMALLEY, RV
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) : 97 - 98
  • [34] A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).
    Wilky, Breelyn A.
    Trucco, Matteo Maria
    Kolonias, Despina
    Wieder, Eric
    Subhawong, Ty
    Rosenberg, Andrew
    Kwon, Deukwoo
    Park, Wungki
    Florou, Vaia
    Kerr, Darcy A.
    Sfakianaki, Efrosyni
    Merchan, Jaime R.
    Komanduri, Krishna
    Trent, Jonathan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group
    Reichardt, P.
    Nielsen, O. S.
    Bauer, S.
    Hartmann, J. T.
    Schoffski, P.
    Christensen, T. B.
    Pink, D.
    Daugaard, S.
    Marreaud, S.
    van Glabbeke, M.
    Blay, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) : 1017 - 1022
  • [36] Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients
    Yovine, A
    Riofrio, M
    Blay, JY
    Brain, E
    Alexandre, J
    Kahatt, C
    Taamma, A
    Jimeno, J
    Martin, C
    Salhi, Y
    Cvitkovic, E
    Misset, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 890 - 899
  • [37] Eribulin mesylate versus eribulin plus anlotinib in patients with advanced or metastatic breast cancer: Results of a phase II study.
    Liu, Liping
    Hu, Zhe-Yu
    Xie, Ning
    Yang, Xiaohong
    Xiao, Huawu
    Li, Jing
    Tian, Can
    Wu, Hui
    Lu, Jun
    Gao, Jianxiang
    Hu, Xuming
    Cao, Min
    Shui, Zhengrong
    Liu, Bingliang
    Ouyang, Quchang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Safety of trabectedin (T) in elderly patients (pts) with advanced soil tissue sarcoma (STS)
    Sanfilippo, Roberta
    Baldi, Giacomo Giulio
    Fumagalli, Elena
    Marrari, Andrea
    Bertulli, Rossella
    Palassini, Elena
    Stacchiotti, Silvia
    Libertini, Michela
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Activity of cribulin mesylate (E7389) in patients with soft tissue sarcoma (STS): Phase II studies of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC 62052).
    Schoffski, P.
    Ray-Coquard, I. L.
    Cioffi, A.
    Bin Bui, N.
    Bauer, S.
    Hartmann, J. T.
    Sciot, R.
    Wanders, J.
    Druyts, D.
    Hohenberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] PHASE-II STUDY OF EPIRUBICIN IN ADVANCED SOFT-TISSUE SARCOMA
    CHEVALLIER, B
    MONTCUQUET, P
    FACHINI, T
    BUI, BN
    KERBRAT, P
    BASTIT, P
    VAN, MV
    BULLETIN DU CANCER, 1990, 77 (10) : 991 - 995
12345